For best experience please turn on javascript and use a modern browser!
You are using a browser that is no longer supported by Microsoft. Please upgrade your browser. The site may not present itself correctly if you continue browsing.
Anne van der Spek, on behalf of the research institute Amsterdam Gastroenterology Endocrinology Metabolism (AGEM) has been awarded a €25,000 AUF Startstipendium to investigate changes in the gut microbiome and their impact on Graves' disease. This grant is made possible by the Spinoza Fund of the Amsterdam University Fund (AUF).
Investigating changes in the gut microbiome and their impact on Graves' disease

Graves' disease (GD) is an autoimmune disease in which thyroid-stimulating antibodies cause overproduction of thyroid hormone. This leads to severe physical and psychological symptoms, in a relatively young patient group. The standard treatment of GD has remained unchanged for more than 50 years. Van der Spek: ‘There is a clear need for new and more effective treatment options for this debilitating disease.’ Her research goes into the intestines of GD patients to look for gut microbes (including bacteria, viruses, yeast and fungi) as a potential cause of GD. This could lead to new treatment options for this disease.